Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells

Clinical Cancer Research

Volumn 7, Issue 8, 2001, Pages 2513-2518

  Sakamoto, Hiroshi ^a,b   Mashima, Tetsuo ^a   Sato, Shigeo ^a   Hashimoto, Yuichi ^b   Yamori, Takao ^a   Tsuruo, Takashi ^a,b  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; ETOPOSIDE; GLUTATHIONE DERIVATIVE; LACTOYLGLUTATHIONE LYASE; METHYLGLYOXAL; MITOGEN ACTIVATED PROTEIN KINASE; S 4 BROMOBENZYLGLUTATHIONE CYCLOPENTYL DIESTER; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; GLYCOLYSIS; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CASPASES; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUTATHIONE; HUMANS; LACTOYLGLUTATHIONE LYASE; LUNG NEOPLASMS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034880918     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. The glyoxalase system: New developments towards functional characterization of a metabolic pathway fundamental to biological life
2. Glyoxalase I activity in human prostate cancer: A potential marker and importance in chemotherapy
3. Glyoxalase I in detoxification: Studies using a glyoxalase I transfectant cell line
4. Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis
5. Antitumor activity of S-p-bromobenzyl-glutathione cyclopentyl diester in vitro and in vivo
6. Mechanism-based competitive inhibitors of glyoxalase I: Intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum
7. Studies of the inhibition of glyoxalase I by S-substituted glutathiones
8. Esterification of reduced glutathione
9. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increase in macromolecular endocytosis
10. Comparison of MTT, XTT and a novel tetrazolium compound MTS for in vitro proliferation and chemosensitivity assays
11. c-Jun NH2-terminal kinase-mediated activation of interleukin-1β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis
12. Hepatocytes sensitized to tumor necrosis factor-α cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways
13. p38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mitochondrial cytochrome c release in ultraviolet B radiation-induced apoptosis
14. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
15. Analysis of glyoxalase-I from normal and tumor tissue from human colon
16. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N-α-acetylarginine, N-α-acetylcysteine, and N-α-acetyllysine, and bovine serum albumin
17. Three distinct signalling responses by murine fibroblasts to genotoxic stress
18. ASKI mediates apoptotic cell death induced by genotoxic stress
19. Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells
20. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases
21. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm
22. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel
23. Generation of a drug resistance profile by quantitation of mdr-I/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen
24. An information-intensive approach to the molecular pharmacology of cancer